Impaired lysosomal acidification triggers iron deficiency and inflammation in vivo

  1. King Faisal Yambire
  2. Christine Rostosky
  3. Takashi Watanabe
  4. David Pacheu-Grau
  5. Sylvia Torres-Odio
  6. Angela Sanchez-Guerrero
  7. Ola Senderovich
  8. Esther G Meyron-Holtz
  9. Ira Milosevic
  10. Jens Frahm
  11. A Phillip West
  12. Nuno Raimundo  Is a corresponding author
  1. University Medical Center Göttingen, Germany
  2. European Neuroscience Institute, Germany
  3. Max-Planck Institute for Biophysical Chemistry, Germany
  4. Texas A&M University Health Science Center, United States
  5. Technion Israel Institute of Technology, Israel

Abstract

Lysosomal acidification is a key feature of healthy cells. Inability to maintain lysosomal acidic pH is associated with aging and neurodegenerative diseases. However, the mechanisms elicited by impaired lysosomal acidification remain poorly understood. We show here that inhibition of lysosomal acidification triggers cellular iron deficiency, which results in impaired mitochondrial function and non-apoptotic cell death. These effects are recovered by supplying iron via a lysosome-independent pathway. Notably, iron deficiency is sufficient to trigger inflammatory signaling in cultured primary neurons. Using a mouse model of impaired lysosomal acidification, we observed a robust iron deficiency response in the brain, verified by in vivo magnetic resonance imaging. Furthermore, the brains of these mice present a pervasive inflammatory signature associated with instability of mitochondrial DNA (mtDNA), both corrected by supplementation of the mice diet with iron. Our results highlight a novel mechanism linking impaired lysosomal acidification, mitochondrial malfunction and inflammation in vivo.

Data availability

We generated RNAseq data from brain of mice (WT and KO), which is deposited in Gene Expression Omnibus under the serial number Series GSE134704.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. King Faisal Yambire

    Institute of Cellular Biochemistry, University Medical Center Göttingen, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Christine Rostosky

    Synaptic Vesicle Recycling, European Neuroscience Institute, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Takashi Watanabe

    Biomedizinische NMR, Max-Planck Institute for Biophysical Chemistry, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. David Pacheu-Grau

    Institute of Cellular Biochemistry, University Medical Center Göttingen, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Sylvia Torres-Odio

    Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Austin, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Angela Sanchez-Guerrero

    Institute of Cellular Biochemistry, University Medical Center Göttingen, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Ola Senderovich

    Faculty of Biotechnology and Food Engineering, Technion Israel Institute of Technology, Haifa, Israel
    Competing interests
    The authors declare that no competing interests exist.
  8. Esther G Meyron-Holtz

    Faculty of Biotechnology and Food Engineering, Technion Israel Institute of Technology, Haifa, Israel
    Competing interests
    The authors declare that no competing interests exist.
  9. Ira Milosevic

    Synaptic Vesicle Recycling, European Neuroscience Institute, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6440-3763
  10. Jens Frahm

    Biomedizinische NMR, Max-Planck Institute for Biophysical Chemistry, Göttingen, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8279-884X
  11. A Phillip West

    Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, Austin, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Nuno Raimundo

    Institute of Cellular Biochemistry, University Medical Center Göttingen, Göttingen, Germany
    For correspondence
    nuno.raimundo@med.uni-goettingen.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5988-9129

Funding

H2020 European Research Council (337327)

  • Nuno Raimundo

Deutsche Forschungsgemeinschaft (SFB1190-P02)

  • Ira Milosevic
  • Nuno Raimundo

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The experiments were performed under the permit 15-883 by the authority for animal research in Lower Saxony, Germany (LAVES).

Copyright

© 2019, Yambire et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 12,741
    views
  • 1,785
    downloads
  • 169
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. King Faisal Yambire
  2. Christine Rostosky
  3. Takashi Watanabe
  4. David Pacheu-Grau
  5. Sylvia Torres-Odio
  6. Angela Sanchez-Guerrero
  7. Ola Senderovich
  8. Esther G Meyron-Holtz
  9. Ira Milosevic
  10. Jens Frahm
  11. A Phillip West
  12. Nuno Raimundo
(2019)
Impaired lysosomal acidification triggers iron deficiency and inflammation in vivo
eLife 8:e51031.
https://doi.org/10.7554/eLife.51031

Share this article

https://doi.org/10.7554/eLife.51031

Further reading

    1. Cell Biology
    Kaima Tsukada, Rikiya Imamura ... Mikio Shimada
    Research Article

    Polynucleotide kinase phosphatase (PNKP) has enzymatic activities as 3′-phosphatase and 5′-kinase of DNA ends to promote DNA ligation and repair. Here, we show that cyclin-dependent kinases (CDKs) regulate the phosphorylation of threonine 118 (T118) in PNKP. This phosphorylation allows recruitment to the gapped DNA structure found in single-strand DNA (ssDNA) nicks and/or gaps between Okazaki fragments (OFs) during DNA replication. T118A (alanine)-substituted PNKP-expressing cells exhibited an accumulation of ssDNA gaps in S phase and accelerated replication fork progression. Furthermore, PNKP is involved in poly (ADP-ribose) polymerase 1 (PARP1)-dependent replication gap filling as part of a backup pathway in the absence of OFs ligation. Altogether, our data suggest that CDK-mediated PNKP phosphorylation at T118 is important for its recruitment to ssDNA gaps to proceed with OFs ligation and its backup repairs via the gap-filling pathway to maintain genome stability.

    1. Cell Biology
    Jittoku Ihara, Yibin Huang ... Koichi Yamamoto
    Research Article

    Chronic kidney disease (CKD) and atherosclerotic heart disease, frequently associated with dyslipidemia and hypertension, represent significant health concerns. We investigated the interplay among these conditions, focusing on the role of oxidized low-density lipoprotein (oxLDL) and angiotensin II (Ang II) in renal injury via G protein αq subunit (Gq) signaling. We hypothesized that oxLDL enhances Ang II-induced Gq signaling via the AT1 (Ang II type 1 receptor)-LOX1 (lectin-like oxLDL receptor) complex. Based on CHO and renal cell model experiments, oxLDL alone did not activate Gq signaling. However, when combined with Ang II, it significantly potentiated Gq-mediated inositol phosphate 1 production and calcium influx in cells expressing both LOX-1 and AT1 but not in AT1-expressing cells. This suggests a critical synergistic interaction between oxLDL and Ang II in the AT1-LOX1 complex. Conformational studies using AT1 biosensors have indicated a unique receptor conformational change due to the oxLDL-Ang II combination. In vivo, wild-type mice fed a high-fat diet with Ang II infusion presented exacerbated renal dysfunction, whereas LOX-1 knockout mice did not, underscoring the pathophysiological relevance of the AT1-LOX1 interaction in renal damage. These findings highlight a novel mechanism of renal dysfunction in CKD driven by dyslipidemia and hypertension and suggest the therapeutic potential of AT1-LOX1 receptor complex in patients with these comorbidities.